ArticleWorld journal of urology2023

Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.

Thierry Lebret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.